Status:
COMPLETED
Enhanced Recovery Program After Laparoscopic Colorectal Surgery During The Era Of COVID-19
Lead Sponsor:
Zagazig University
Conditions:
Colorectal Disorders
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The investigators included all patients who were subjected to laparoscopic colorectal surgery at investigators' center between ( December 2019 to December 2021) for benign \& malignant conditions. sam...
Detailed Description
The investigators included all patients who were subjected to laparoscopic colorectal surgery at investigators' center between ( December 2019 to December 2021) for benign \& malignant conditions. The...
Eligibility Criteria
Inclusion
- Patients with age ranged from 20-75 years
- patients who had no contraindication for laparoscopic surgery
- good general condition with American society of anesthesiology (ASA) I \& II
Exclusion
- patients who had bad general condition (ASA ≥3)
- patients with age above 75 years
- patients with uncompensated cardiopulmonary disease , immunological disorders ,immunosuppressive therapy for any cause.
- Patients who had chronic liver disease
- patients who underwent emergency laparotomy and had a stoma created for them or those with metastasis
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05240053
Start Date
December 1 2019
End Date
December 1 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University Hospitals
Zagazig, Sharqua, Egypt, 1185